Plasma lipid levels and psychologic characteristics in men

American Journal of Epidemiology

Volumn 141, Issue 6, 1995, Pages 507-517

  Freedman, David S ^a   Byers, Tim ^a   Barrett, Drue H ^a   Stroup, Nancy E ^a   Eaker, Elaine ^b   Monroe blum, Heather ^c  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^b MARSHFIELD CLINIC   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

Antisocial personality disorder, anxiety disorders; Depressive disorders; Lipids; Neuropsychological tests

Indexed keywords

CATECHOLAMINE; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; TRIACYLGLYCEROL;

ADULT; ANTISOCIAL BEHAVIOR; ANXIETY NEUROSIS; ARTICLE; CHOLESTEROL BLOOD LEVEL; DEPRESSION; HOSTILITY; HUMAN; HYPERCHOLESTEROLEMIA; HYPOCHONDRIASIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OBSESSION;

ADULT; ANTISOCIAL PERSONALITY DISORDER; ANXIETY DISORDERS; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; HUMAN; HYPOCHONDRIASIS; LIPOPROTEINS, HDL CHOLESTEROL; MALE; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; TRIGLYCERIDES; VETERANS; WHITES;

EID: 0028906089     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a117465     Document Type: Article

References (51)

1. Holme I. An analysis of randomized trials evaluating the effect of cholesterol reduction on total mortality and coronary heart disease incidence. Circulation 1990;82:1916-24.
2. Rossouw JE, Lewis B, Rifkind BM. The value of lowering cholesterol after myocardial infarction. N Engl J Med 1990; 323:1112-19.
3. Muldoon MF, Manuck SB, Mathews KA. Lowering cholesterol concentration and mortality: a quantitative review of primary prevention trials. BMJ 1990;301:309-14.
4. Wysowski DK, Gross TP. Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs. Arch Intern Med 1990;150:2169-72.
5. Multiple Risk Factor Intervention Trial Research Group. Serum cholesterol levels and mortality findings for men screened in the Multiple Risk Factor Intervention Trial. Arch Intern Med 1992;152:1490-1500.
6. Jacobs D, Blackburn H, Higgins M, et al. Report on the conference on low blood cholesterol: mortality associations. Circulation 1992;86:1046-60.
7. Smith GD, Shipley MJ, Marmot MG, et al. Plasma cholesterol concentrations and mortality. The Whitehall Study. JAMA 1992;267:70-6.
8. Klag MJ, Mead LA Ford DE, et al. Serum cholesterol in young men and risk of subsequent injuries. (Abstract). Circulation 1993;88:1-124.
9. Friedman M, Rosenman RH, Carroll V. Changes in the serum cholesterol and blood clotting time in men subjected to cyclic variation of occupational stress. Circulation 1958;17:852-61.
10. Niaura R, Stoney CM, Herbert PN. Lipids in psychological research: the last decade. Biol Psychol 1992;34:1-43.
11. Lundberg U, Hedman M, Melin B, et al. Type A behavior in healthy males and females as related to physiological reactivity and blood lipids. Psychosom Med 1989;51:113-22.
12. van Doomen LJP, van Blokland R. Serum-cholesterol: sex specific psychological correlates during rest and stress. J Psychosom Res 1987;31:239-49.
13. Dujovne VF, Houston BK. Hostility-related variables and plasma lipid levels. J Behav Med 1991;14:555-65.
14. Hatch FT, Reisiell PK, Poon-King TMW, et al. A study of coronary heart disease in young men: characteristics and metabolic studies of patients and comparison with age-matched healthy men. Circulation 1966;33:679-703.
15. Virkkunen M. Serum cholesterol in antisocial personality. Neuropsychobiology 1979;5:27-30.
16. Virkkunen M, Penttinen H. Serum cholesterol in aggressive conduct disorder: a preliminary study. Biol Psychiatry 1984; 19:435-9.
17. Morgan RE, Palinkas LA Barrett-Connor E, et al. Plasma cholesterol and depressive symptoms in older men. Lancet 1993;341:75-9.
18. Kaplan JR., Manuck SB, Shively C. The effects of fat and cholesterol on social behavior in monkeys. Psychosom Med 1991;53:634-42.
19. Centers for Disease Control Vietnam Experience Study. Health status of Vietnam veterans. I. Psychosocial characteristics. JAMA 1988;259:2701-7.
20. Freedman DS, Strogatz DS, Eaker E, et al. Differences between black and white men in correlates of high-density lipoprotein cholesterol. Am J Epidemiol 1990;132:656-69.
21. US Department of Health and Human Services. National drug code directory. 1985 ed. Washington, DC: Department of Health and Human Services, 1985. (DHHS publication no. (FDA) 85-1077).
22. Yeragani VK, Balon R, Pohl R, et al. Imipramine treatment and increased serum cholesterol levels. (Letter). Can J Psychiatry 1989;34:845.
23. Centers for Disease Control. Health status of Vietnam Veterans. Suppl. A Laboratory methods and quality control. Atlanta, GA: US Department of Health and Human Services, 1989.
24. Robins LN, Helzer JE, Orvaschel H, et al. The Diagnostic Interview Schedule. In: Eaton WW, Kessler LG, eds. Epidemiologic field methods in psychiatry. The NIMH Epidemiologic Catchment Area Program. Orlando, FL: Academic Press, Inc., 1985:143-70.
25. Centers for Disease Control. Health status of Vietnam veterans. Vol. 4. Psychological and neuropsychological evaluation. Atlanta, GA: US Department of Health and Human Services, 1989.
26. Burke JD. Diagnostic categorization by the Diagnostic Interview Schedule (DIS): a comparison with other methods of assessment. In: Barrett JE, Rose RM, eds. Mental disorders in the community. New York, NY: Guilford Press, 1986: 255-85.
27. Boyd JH, Burke JD, Gruenberg E, et al. Exclusion criteria of DSM-I1I: a study of co-occurrence of hierarchy-free syndromes. Arch Gen Psychiatry 1984;41:983-9.
28. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Third ed. Washington, DC: American Psychiatric Association, 1980.
29. Greene RL. The MMPI. An interpretive manual. New York, NY: Grune & Stratton, 1980.
30. Flanders WD, DerSimonian R, Freedman DS. Interpretation of linear regression models that include transformations or interaction terms. Ann Epidemiol 1992;2:735-44.
31. Fowkes FGR, Leng GC, Donnan PT, et al. Serum cholesterol, triglycerides, and aggression in the general population. Lancet 1992;340:995-8.
32. Rosenman RH, Brand RJ, Jenkins D, et al. Coronary heart disease in the Western Collaborative Group Study: final follow-up experience of 8V2 years. JAMA 1975;233:872-7.
33. Shekelle RB, Hulley SB, Neaton JD, et al. The MRF1T behavior pattern study, n. Type A behavior and incidence of coronary heart disease. Am J Epidemiol 1985;122:559-70.
34. Suis J. Type A behavior pattern. The role of anxiety, selfawareness and denial. In: Byrne DG, Rosenman R, eds. Anxiety and the heart. New York, NY: Hemisphere Publishing Corp, 1990:259-76.
35. Dimsdale JE, Herd JA. Variability of plasma lipids in response to emotional arousal. Psychosom Med 1982;44:413-30.
36. McCann BS, Wamick R, Knopp RH. Changes in plasma lipids and dietary intake accompanying shifts in perceived workload and stress. Psychosom Med 1990;52:86-96.
37. Mathew RJ, Ho BT, Kralik P, et al. Catechol-O-methyltrans- ferase and catecholamines in anxiety and relaxation. Psychiatry Res 1980;3:85-91.
38. Williams RB Jr. Biological mechanisms mediating the relationship between behavior and coronary heart disease. In: Siegman AW, Dembroski TM, eds. In search of coronary- prone behavior beyond type A. Hillsdale, NJ: Lawrence Erlbaum Associates, 1989:195-206.
39. Virkkunen M. Serum cholesterol levels in homicidal offenders. A low cholesterol level is connected with a habitually violent tendency under the influence of alcohol. Neuropsychobiology 1983;10:65-9.
40. Jenkins CD, Harnes CG, Zyzanski SJ, et al. Psychological traits and serum lipids. I. Findings from the California Psychological Inventory. Psychosom Med 1969;31:115-27.
41. Stewart MA, Stewart SG. Serum cholesterol in antisocial personality. A failure to replicate earlier findings. Neuropsychobiology 1981;7:9-11.
42. Dabbs JM Jr., Hopper CH, Jurkovic GJ. Testosterone and personality among college students and military veterans. Person Individ Diff 1990;11:1263-9.
43. Jacobs DR Jr. Why is low blood cholesterol associated with risk of nonatherosclerotic disease death? Ann Rev Public Health 1993;14:95-114.
44. Preston-Mason R, Herbette LG, Silverman DI. Can altering serum cholesterol affect neurologic function? J Mol Cell Cardiol 1991;23:1339-42.
45. Engelberg H. Low serum cholesterol and suicide. Lancet 1992;339:727-9.
46. Mann JJ, Marzuk PM, Arango V, et al. Neurochemical studies of violent and nonviolent suicide. Psychopharmacol Bull 1989;25:407-13.
47. Muldoon MF, Kaplan JR., Manuck SB, et al. Effects of a low-fat diet on brain serotonergic responsivity in cynomol- gous monkeys. Biol Psychiatry 1992;31:739-42.
48. Rogler LH, Malgady RG, Tyron WW. Evaluation of mental health. Issues of memory in the Diagnostic Interview Schedule. J Nerv Ment Dis 1992;180:215-22.
49. Robins LN. Diagnostic grammar and assessment: translating criteria into questions. Psychol Med 1989;19:57-68.
50. Subar AF, Harlan LC, Mattson ME. Food and nutrient intake differences between smokers and non-smokers in the US. Am J Public Health 1990;80:1323-9.
51. La Vecchia C, Negri E, Franceschi S, et al. Differences in dietary intake with smoking alcohol, and education. Nutr Cancer 1992;17:297-304.